These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2785102)

  • 1. In-vitro activity of tigemonam, an oral monobactam, against gram-negative rods, including variants in beta-lactamase-production.
    Brown J; Yang YJ; Livermore DM
    J Antimicrob Chemother; 1989 Feb; 23(2):201-7. PubMed ID: 2785102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibacterial activity of tigemonam dicholate (SQ 30836) and interaction with beta-lactamases of gram-negative bacteria.
    Raimondi A; Cocuzza CE
    J Chemother; 1989 May; 1 Suppl 2():13-21. PubMed ID: 2809698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro evaluation of tigemonam, a novel oral monobactam.
    Tanaka SK; Summerill RA; Minassian BF; Bush K; Visnic DA; Bonner DP; Sykes RB
    Antimicrob Agents Chemother; 1987 Feb; 31(2):219-25. PubMed ID: 3105448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tigemonam, an oral monobactam.
    Chin NX; Neu HC
    Antimicrob Agents Chemother; 1988 Jan; 32(1):84-91. PubMed ID: 3279906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro antimicrobial activity of tigemonam, a new orally administered monobactam.
    Fuchs PC; Jones RN; Barry AL
    Antimicrob Agents Chemother; 1988 Mar; 32(3):346-9. PubMed ID: 3259122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tigemonam activity against clinical isolates of Enterobacteriaceae and Enterobacteriaceae with known mechanisms of resistance to beta-lactam antibiotics.
    Nélet F; Gutmann L; Kitzis MD; Acar JF
    J Antimicrob Chemother; 1989 Aug; 24(2):173-81. PubMed ID: 2676940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative in-vitro activity of tigemonam, a new monobactam.
    Rylander M; Gezelius L; Norrby SR
    J Antimicrob Chemother; 1988 Sep; 22(3):307-13. PubMed ID: 3182428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro antibacterial activity and beta-lactamase stability of CP-70,429 a new penem antibiotic.
    Minamimura M; Taniyama Y; Inoue E; Mitsuhashi S
    Antimicrob Agents Chemother; 1993 Jul; 37(7):1547-51. PubMed ID: 8363389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibacterial Activity of Tigemonam Dicholate (SQ 30836) and Interaction With Beta-Lactamases of Gram-Negative Bacteria.
    Raimondi A; Cocuzza CE
    J Chemother; 1989 May; 1(sup2):13-21. PubMed ID: 27416144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects on beta-lactam susceptibility of phenotypic induction and genotypic derepression of beta-lactamase synthesis.
    Shannon K; Phillips I
    J Antimicrob Chemother; 1986 Dec; 18 Suppl E():15-22. PubMed ID: 3102451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The anti-microbial activity, beta-lactamase stability, and disk diffusion susceptibility testing of carumonam (RO 17-2301, AMA-1080), a new monobactam.
    Jones RN; Barry AL; Thornsberry C; Fuchs PC; Packer RR
    Am J Clin Pathol; 1986 Nov; 86(5):608-18. PubMed ID: 3096130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparable evaluation of orally active beta-lactam compounds in ampicillin-resistant gram-positive and gram-negative rods: role of beta-lactamases on resistance.
    Cullmann W; Dick W; Stieglitz M; Opferkuch W
    Chemotherapy; 1988; 34(3):202-15. PubMed ID: 3262045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Importance of beta-lactamase induction.
    Phillips I; Shannon K
    Eur J Clin Microbiol Infect Dis; 1993; 12 Suppl 1():S19-26. PubMed ID: 8477758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type I beta-lactamases of gram-negative bacteria: interactions with beta-lactam antibiotics.
    Sanders CC; Sanders WE
    J Infect Dis; 1986 Nov; 154(5):792-800. PubMed ID: 3490520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibacterial activity in vitro of tigemonam, a new oral monobactam.
    Schito GC; Debbia E; Bandelloni R; Paglia P; Pesce A
    J Chemother; 1989 May; 1 Suppl 2():41-4. PubMed ID: 2809702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro susceptibility of characterized β-lactamase-producing Gram-negative bacteria isolated in Japan to ceftazidime-, ceftaroline-, and aztreonam-avibactam combinations.
    Yoshizumi A; Ishii Y; Aoki K; Testa R; Nichols WW; Tateda K
    J Infect Chemother; 2015 Feb; 21(2):148-51. PubMed ID: 25444674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aztreonam: the first monobactam.
    Sykes RB; Bonner DP
    Am J Med; 1985 Feb; 78(2A):2-10. PubMed ID: 3871589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of tigemonam against multiresistant nosocomial Enterobacteriaceae.
    Giamarellou H; Pephanis A; Grammatikou M; Avlamis A; Papoulias G
    J Chemother; 1989 May; 1 Suppl 2():32-5. PubMed ID: 2809700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The new monobactams: chemistry and biology.
    Sykes RB; Koster WH; Bonner DP
    J Clin Pharmacol; 1988 Feb; 28(2):113-9. PubMed ID: 3360965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of chromosomal beta-lactamases to beta-lactam resistance in enterobacteria.
    Lindberg F; Normark S
    Rev Infect Dis; 1986; 8 Suppl 3():S292-304. PubMed ID: 3529322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.